Hangzhou Alltest Biotech Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

4.08

Vol. 1Y

—

Shs. 5Y

5.84%

Rev. 5Y

-4.43%

Div Yld LY

—

Div Yld TTM

—

Revenues

905m

+4.47%

Net income

220m

-27.20%

CFO

207m

-37.31%

Dividend

Jun 01, 20261 /sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Hangzhou Alltest Biotech Co., Ltd. operates internationally, specializing in the entire process of in vitro diagnostic reagents, from their initial research and development to manufacturing and market distribution. The company supplies a wide array of rapid diagnostic solutions, encompassing crucial health sectors like women's health, infectious disease detection, drug screening, cancer diagnostics, and cardiovascular conditions, among other distinct product series. This enterprise is headquartered in Hangzhou, China.

URL

https://www.alltests.com.cn/

IPO date

Mar 25, 2021

Employees

Domiciled in

Incorporated in

Valuation

Latest on right Latest on left

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT